Small doses of nicotine can halt the progression of the often-fatal condition called sepsis, according to experiments in mice. The finding, coupled with tests of nicotine on cultured human cells, suggests a pathway to more-effective therapies for the infection-triggered problem.
Twice as many mice injected with nicotine survived at least 3 weeks after sepsis set in than did mice receiving inert injections.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.